Brief: Apogee Therapeutics, Inc. Announces Pricing Of $300 Million Underwritten Public Offering
Apogee Therapeutics Inc APGE.O: APOGEE THERAPEUTICS, INC. ANNOUNCES PRICING OF $300 MILLION UNDERWRITTEN PUBLIC OFFERING APOGEE THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 6,951,221 SHARES AT $41.00 EACH Source text: ID:nGNXbQD1tW Further company coverage: APGE.O
Recent news on Apogee Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Abbvie Seeks At Least $8 Billion In Debt To Fund Apogee Deal - Bloomberg News
Street View: Strength in AbbVie's immunology pipeline to support revenue growth
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates (updated)